The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: Differences in α4β2 nicotinic receptor activation

European Journal of Pharmacology

Volumn 654, Issue 1, 2011, Pages 47-52

  Cunningham, Colin S ^a   McMahon, Lance R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Behavior; Cytisine; Dihydro erythroidine; Mecamylamine; Nicotine; Varenicline

Indexed keywords

CYTISINE; NICOTINE TARTRATE; NICOTINIC RECEPTOR ALPHA4BETA2; VARENICLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; IN VIVO STUDY; INSTRUMENTAL CONDITIONING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOKING CESSATION;

ALKALOIDS; ANIMALS; AZOCINES; BENZAZEPINES; CONDITIONING, OPERANT; DIHYDRO-BETA-ERYTHROIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; MALE; MECAMYLAMINE; MICE; MICE, INBRED C57BL; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; QUINOLIZINES; QUINOXALINES; RECEPTORS, NICOTINIC; REINFORCEMENT SCHEDULE; SMOKING CESSATION; TIME FACTORS;

EID: 78951482359     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.12.003     Document Type: Article

References (27)

1. F.I. Carroll, Y. Yokota, W. Ma, J.R. Lee, L.E. Brieaddy, J.P. Burgess, H.A. Navarro, M.I. Damaj, and B.R. Martin Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3′-(substituted phenyl)deschloroepibatidine analogs Bioorg. Med. Chem. 16 2008 746 754
2. J.W. Coe, P.R. Brooks, M.G. Vetelino, M.C. Wirtz, E.P. Arnold, J. Huang, S.B. Sands, T.I. Davis, L.A. Lebel, C.B. Fox, A. Shrikhande, J.H. Heym, E. Schaeffer, H. Rollema, Y. Lu, R.S. Mansbach, L.K. Chambers, C.C. Rovetti, D.W. Schulz, F.D. Tingley III, and B.T. O'Neill Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation J. Med. Chem. 48 2005 3474 3477
3. M.I. Damaj, M. Fei-Yin, M. Dukat, W. Glassco, R.A. Glennon, and B.R. Martin Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice J. Pharmacol. Exp. Ther. 284 1998 1058 1065
4. J.F. Etter Cytisine for smoking cessation: a literature review and a meta-analysis Arch. Intern. Med. 166 2006 1553 1559
5. T.P. George, and S.S. O'Malley Current pharmacological treatments for nicotine dependence Trends Pharmacol. Sci. 25 2004 42 48
6. S.R. Goldberg, M.E. Risner, I.P. Stolerman, C. Reavill, and H.S. Garcha Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats Psychopharmacology (Berl.) 97 1989 295 302
7. T.P. Kenakin Pharmacologic analysis of drug-receptor interaction 3rd ed. 1997 Lippincott-Raven Publishers Philadelphia
8. M.G. LeSage, D. Shelley, J.T. Ross, F.I. Carroll, and W.A. Corrigall Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats Pharmacol. Biochem. Behav. 91 2009 461 467
9. C.W. Luetje, and J. Patrick Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors J. Neurosci. 11 1991 837 845
10. S.E. McCallum, N. Parameswaran, T. Bordia, H. Fan, J.M. McIntosh, and M. Quik Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys J. Pharmacol. Exp. Ther. 318 2006 381 388
11. K.B. Mihalak, F.I. Carroll, and C.W. Luetje Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Mol. Pharmacol. 70 2006 801 805
12. C.F. Morrison Effects of nicotine on operant behaviour of rats Int. J. Neuropharmacol. 6 1967 229 240
13. R. Nashmi, and H.A. Lester CNS localization of neuronal nicotinic receptors J. Mol. Neurosci. 30 2006 181 184
14. C. Naylor, D. Quarta, C. Fernandes, and I.P. Stolerman Tolerance to nicotine in mice lacking alpha7 nicotinic receptors Psychopharmacology 180 2005 558 563
15. R.L. Papke, L.P. Dwoskin, and P.A. Crooks The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery J. Neurochem. 101 2007 160 167
16. R.L. Papke, and S.F. Heinemann Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit Mol. Pharmacol. 45 1994 142 149
17. R.L. Papke, and J.K. Porter Papke Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis Br. J. Pharmacol. 137 2002 49 61
18. R.L. Papke, P.R. Sanberg, and R.D. Shytle Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes J. Pharmacol. Exp. Ther. 297 2001 646 656
19. H. Rollema, L.K. Chambers, J.W. Coe, J. Glowa, R.S. Hurst, L.A. Lebel, Y. Lu, R.S. Mansbach, R.J. Mather, C.C. Rovetti, S.B. Sands, E. Schaeffer, D.W. Schulz, F.D. Tingley, and K.E. Williams Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 52 2007 985 994
20. H. Rollema, A. Shrikhande, K.M. Ward, F.D. Tingley III, J.W. Coe, B.T. O'Neill, E. Tseng, E.Q. Wang, R.J. Mather, R.S. Hurst, K.E. Williams, M. de Vries, T. Cremers, S. Bertrand, and D. Bertrand Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence Br. J. Pharmacol. 160 2010 334 345
21. J.W. Smith, A. Mogg, E. Tafi, E. Peacey, I.A. Pullar, P. Szekeres, and M. Tricklebank Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat Psychopharmacology (Berl.) 190 2007 157 170
22. R.D. Spealman, S.R. Goldberg, and M.L. Gardner Behavioral effects of nicotine: schedule-controlled responding by squirrel monkeys J. Pharmacol. Exp. Ther. 216 1981 484 491
23. I.P. Stolerman, C.J. Chandler, H.S. Garcha, and J.M. Newton Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats Psychopharmacology (Berl.) 129 1997 390 397
24. I.P. Stolerman, R. Fink, and M.E. Jarvik Acute and chronic tolerance to nicotine measured by activity in rats Psychopharmacologia 30 1973 329 342
25. R.J. Tallarida Drug synergism and dose-effect data analysis 2000 Chapman & Hall/CRC Boca Raton
26. T. Tritto, S.E. McCallum, S.A. Waddle, S.R. Hutton, R. Paylor, A.C. Collins, and M.J. Marks Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia Nicotine Tob. Res. 6 2004 145 158
27. M. Williams, and J.L. Robinson Binding of nicotinic cholinergic antagonist, dihydro-β-erythroidine, to rat brain tissue J. Neuroimmunol. 4 1984 2906 2911